GECOSS CORPORATION Logo

GECOSS CORPORATION

Leases and sells temporary steel materials and equipment for large construction projects.

9991 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
文京区後楽二丁目5番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

GECOSS CORPORATION is a company specializing in the leasing and sale of materials and machinery for the construction industry. Its core business involves providing heavy-duty temporary construction materials, with a focus on steel products, as well as construction equipment. The company also offers associated services, including engineering, installation, and repair for its products. GECOSS supports a range of large-scale civil engineering and construction projects, such as urban redevelopment, underground construction, and the installation of temporary bridges, positioning itself as a key supplier and solutions provider for the construction sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-23 09:38
Post-Annual General Meeting Information
臨時報告書
Japanese 26.6 KB
2025-06-19 09:14
Governance Information
内部統制報告書-第58期(2024/04/01-2025/03/31)
Japanese 24.3 KB
2025-06-19 09:13
Registration Form
確認書
Japanese 8.6 KB
2025-06-19 09:11
Registration Form
有価証券報告書-第58期(2024/04/01-2025/03/31)
Japanese 1.8 MB
2024-11-01 07:15
Interim Report
確認書
Japanese 8.7 KB
2024-11-01 07:14
Interim Report
半期報告書-第58期(2024/04/01-2025/03/31)
Japanese 233.5 KB
2024-06-20 09:51
Post-Annual General Meeting Information
臨時報告書
Japanese 30.8 KB
2024-06-20 08:27
Regulatory News Service
内部統制報告書-第57期(2023/04/01-2024/03/31)
Japanese 23.9 KB
2024-06-20 08:23
Regulatory News Service
確認書
Japanese 8.7 KB
2024-06-20 08:14
Annual Report
有価証券報告書-第57期(2023/04/01-2024/03/31)
Japanese 1.6 MB
2024-05-10 08:06
Regulatory News Service
臨時報告書
Japanese 26.1 KB
2024-02-01 07:17
Regulatory News Service
確認書
Japanese 8.9 KB
2024-02-01 07:15
Quarterly Report
四半期報告書-第57期第3四半期(2023/10/01-2023/12/31)
Japanese 187.5 KB
2023-11-02 07:36
Regulatory News Service
確認書
Japanese 8.7 KB
2023-11-02 07:33
Quarterly Report
四半期報告書-第57期第2四半期(2023/07/01-2023/09/30)
Japanese 221.8 KB

Automate Your Workflow. Get a real-time feed of all GECOSS CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GECOSS CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.